Nakisa Serry

Part of Bristol Myers Squibb Co., Celgene Europe Ltd. is a British company that engages in research and development in pharmaceutical products. The company is based in Middlesex, UK.

Part of Bristol Myers Squibb Co., Celgene UK Holdings Ltd. functions as an investment holding company. The company is based in London, UK.

Part of Bristol Myers Squibb Co., Celgene UK Manufacturing (II) Ltd. functions as an investment holding company. The company is based in London, UK.

Part of Bristol Myers Squibb Co., Celgene UK Manufacturing Ltd. functions as an investment holding company. The company is based in London, UK.

Galderma Pharma SA discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. It offers drugs, medical dermatology solutions, and therapeutic skin care products for treating hair, nail, and skin diseases. The company was founded in 1981 and is headquartered in Lausanne, Switzerland.

Celgene Ltd. engages in the development of human pharmaceuticals and agrochemicals. It focuses on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. The company was founded on June 2, 2015 and is headquartered in Uxbridge, the United Kingdom.